Gastrointestinal Tolerance Clinical Trial
Official title:
Gastrointestinal Tolerance, Satiation and Sensory Acceptance of Yogurts Containing Dietary Fiber and Coffee Cascara Extract.
Coffee processing byproducts, such as coffee cascara (outer skin and pulp of the coffee berry), have potential health promoting properties due to the presence of bioactive compounds. Its use as a novel food ingredient is a means of valorizing this fractioin in the elaboration of functional yogurts. The addition of cascara extract in yogurt affects its texture quality. The addition of dietary fiber can help regain the structure of the yogurt's gel. However, secondary gastrointestinal effects associated with acute fiber ingestion must be considered.The aim of this clinical trial is to study the gastrointestinal tolerance, satiation and sensory acceptance of yogurts containing both coffee cascara extract and different doses of commercial soluble dietary fiber.
Forty healthy volunteers will be recruited and distributed into 4 groups following a
randomized, blind, crossover design. Yogurt formulations will be administered two hours after
the ingestion of a standardized breakfast, as a snack. Yogurt formulations include:
- Control cascara yogurt with 0% dietary fiber.
- Cascara yogurt with 3% dietary fiber.
- Cascara yogurt with 7% dietary fiber.
- Cascara yogurt with 13% dietary fiber.
The study will be conducted in 4 sessions, with at least 48h of washout period between
treatment days. Data on gastrointestinal tolerance, satiation and sensory acceptance will be
taken on the same day of the treatment using online surveys.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT04100460 -
A Double Blind Study on the Gastrointestinal Effects of Arabinoxylan (Leaf Fiber Extract).
|
N/A | |
| Completed |
NCT00977964 -
Tolerance of Healthy Term Infants Fed Infant Formulas #3
|
Phase 3 | |
| Not yet recruiting |
NCT05827198 -
Evaluating the Impact of Incremental Doses of a Sugar Replacer Blend on Gastrointestinal Tolerance in Candies
|
N/A | |
| Completed |
NCT03945149 -
A Clinical Trial to Evaluate the Chronic Safety and Tolerance of Turmipure Gold™ in Healthy Subjects
|
N/A | |
| Active, not recruiting |
NCT05369494 -
Infants Fed a Hydrolyzed Infant Formula
|
N/A | |
| Completed |
NCT02757924 -
Behavior of Infants Fed Formula Supplemented With Prebiotics
|
N/A | |
| Completed |
NCT05213494 -
The Effects of Soluble Corn Fiber on Gastrointestinal Tolerance and Fecal Microbiome in Healthy Children
|
N/A | |
| Completed |
NCT05051202 -
A Study Assessing the Tolerable Upper Intake Level and Safety of Sugars From Fiber
|
N/A | |
| Completed |
NCT01902212 -
Evaluation of an Oral Nutrition Supplement
|
N/A | |
| Completed |
NCT03597113 -
Evaluation of Infants Fed an Extensively Hydrolyzed Hypo Allergenic Infant Formula
|
||
| Completed |
NCT04745455 -
Gastrointestinal Tolerance and Safety of an Infant Formula Containing Prebiotics, Probiotics and Postbiotics.
|
N/A | |
| Completed |
NCT02322138 -
Gastrointestinal Tolerance of Infant Formula
|
N/A | |
| Completed |
NCT04945083 -
Evaluation of a High Protein, High Calorie Pudding in Adults With/or at Risk for Malnutrition
|
N/A | |
| Completed |
NCT03648255 -
TolerUp Enteral Feeding Protocol
|
||
| Completed |
NCT03769012 -
Ability of Beta-glucan Supplementation to Augment Immune Function
|
N/A | |
| Completed |
NCT02456831 -
Soy Formula Feedings in Healthy, Term Infants
|
N/A | |
| Completed |
NCT03628183 -
Tolerance of Infants Fed a Hydrolysate Formula
|
N/A | |
| Completed |
NCT02456805 -
Alternate Formula Feedings in Formula Intolerant Infants
|
N/A | |
| Recruiting |
NCT04966299 -
Effect of Daily Erythritol Versus Sucrose Intake Over 5 Weeks on Glucose Tolerance in Adolescents
|
N/A | |
| Completed |
NCT02746016 -
Effect of Formula on Infant Behavior
|
N/A |